These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 37396503)

  • 1. New insight of obesity-associated NAFLD: Dysregulated "crosstalk" between multi-organ and the liver?
    Wang YD; Wu LL; Qi XY; Wang YY; Liao ZZ; Liu JH; Xiao XH
    Genes Dis; 2023 May; 10(3):799-812. PubMed ID: 37396503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insight into inter-organ crosstalk contributing to the pathogenesis of non-alcoholic fatty liver disease (NAFLD).
    Zhang X; Ji X; Wang Q; Li JZ
    Protein Cell; 2018 Feb; 9(2):164-177. PubMed ID: 28643267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of organokines in the development of NAFLD/NASH associated hepatocellular carcinoma.
    Vachher M; Bansal S; Kumar B; Yadav S; Arora T; Wali NM; Burman A
    J Cell Biochem; 2022 Oct; 123(10):1553-1584. PubMed ID: 35818831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Stomach as an Endocrine Organ: Expression of Key Modulatory Genes and Their Contribution to Obesity and Non-alcoholic Fatty Liver Disease (NAFLD).
    Birerdinc A; Stoddard S; Younossi ZM
    Curr Gastroenterol Rep; 2018 Apr; 20(6):24. PubMed ID: 29675753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD).
    Buzzetti E; Pinzani M; Tsochatzis EA
    Metabolism; 2016 Aug; 65(8):1038-48. PubMed ID: 26823198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perilipin-2 promotes obesity and progressive fatty liver disease in mice through mechanistically distinct hepatocyte and extra-hepatocyte actions.
    Orlicky DJ; Libby AE; Bales ES; McMahan RH; Monks J; La Rosa FG; McManaman JL
    J Physiol; 2019 Mar; 597(6):1565-1584. PubMed ID: 30536914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrine causes of nonalcoholic fatty liver disease.
    Marino L; Jornayvaz FR
    World J Gastroenterol; 2015 Oct; 21(39):11053-76. PubMed ID: 26494962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organokines and Exosomes: Integrators of Adipose Tissue Macrophage Polarization and Recruitment in Obesity.
    Wang YY; Wang YD; Qi XY; Liao ZZ; Mai YN; Xiao XH
    Front Endocrinol (Lausanne); 2022; 13():839849. PubMed ID: 35273574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-Alcoholic Steatohepatitis (NASH) and Organokines: What Is Now and What Will Be in the Future.
    Santos JPMD; Maio MC; Lemes MA; Laurindo LF; Haber JFDS; Bechara MD; Prado PSD; Rauen EC; Costa F; Pereira BCA; Flato UAP; Goulart RA; Chagas EFB; Barbalho SM
    Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease.
    Rosso C; Kazankov K; Younes R; Esmaili S; Marietti M; Sacco M; Carli F; Gaggini M; Salomone F; Møller HJ; Abate ML; Vilstrup H; Gastaldelli A; George J; Grønbæk H; Bugianesi E
    J Hepatol; 2019 Nov; 71(5):1012-1021. PubMed ID: 31301321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organokines in disease.
    Chung HS; Choi KM
    Adv Clin Chem; 2020; 94():261-321. PubMed ID: 31952573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones.
    Geisler CE; Renquist BJ
    J Endocrinol; 2017 Jul; 234(1):R1-R21. PubMed ID: 28428362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiponectin and PPAR: a setup for intricate crosstalk between obesity and non-alcoholic fatty liver disease.
    Ishtiaq SM; Rashid H; Hussain Z; Arshad MI; Khan JA
    Rev Endocr Metab Disord; 2019 Sep; 20(3):253-261. PubMed ID: 31656991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism.
    Kim TH; Hong DG; Yang YM
    Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver sympathetic denervation reverses obesity-induced hepatic steatosis.
    Hurr C; Simonyan H; Morgan DA; Rahmouni K; Young CN
    J Physiol; 2019 Sep; 597(17):4565-4580. PubMed ID: 31278754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TSH-SPP1/TRβ-TSH positive feedback loop mediates fat deposition of hepatocyte: Crosstalk between thyroid and liver.
    Huang B; Wen W; Ye S
    Front Immunol; 2022; 13():1009912. PubMed ID: 36300106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of VEGF-B signaling prevents non-alcoholic fatty liver disease development by targeting lipolysis in the white adipose tissue.
    Falkevall A; Mehlem A; Folestad E; Ning FC; Osorio-Conles Ó; Radmann R; de Hollanda A; Wright SD; Scotney P; Nash A; Eriksson U
    J Hepatol; 2023 May; 78(5):901-913. PubMed ID: 36717026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between hepatic and systemic angiopoietin-like 3, hepatic Vitamin D receptor expression and NAFLD in obesity.
    Barchetta I; Cimini FA; Chiappetta C; Bertoccini L; Ceccarelli V; Capoccia D; Gaggini M; Di Cristofano C; Della Rocca C; Silecchia G; Leonetti F; Lenzi A; Gastaldelli A; Cavallo MG
    Liver Int; 2020 Sep; 40(9):2139-2147. PubMed ID: 32510837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inter-Organ Crosstalk in the Development of Obesity-Associated Insulin Resistance.
    Piquet M; Martínez MC; Romacho T
    Handb Exp Pharmacol; 2022; 274():205-226. PubMed ID: 34853949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Advances in Adipose Tissue Dysfunction and Its Role in the Pathogenesis of Non-Alcoholic Fatty Liver Disease.
    Wang X; Rao H; Liu F; Wei L; Li H; Wu C
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.